Exane Derivatives’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Exane Derivatives’s Portfolio ONCE Stock Details ONCE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell
2019 Q3	$1.94K	Hold
2019 Q2	$2.05K	Hold
2019 Q1	$2.28K	Hold
2018 Q4	$783	Hold
2018 Q3	$1.09K	Sell
2018 Q2	$175K	Hold
2018 Q1	$136K	Buy